Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Launched by TECHNISCHE UNIVERSITÄT DRESDEN · Oct 10, 2005
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
daily psoriasis plaque tests for two weeks and optical coherence tomography (OCT) and 20-MHz-ultrasound on day 0 and day 11, 10 days post end of treatment and 20 days post end of treatment
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 18 Years
- • Negative urine pregnancy test
- • Written informed consent
- • Good compliance
- Exclusion Criteria:
- • Patients less than 18 years
- • Pregnant patients
- • Patients with renal insufficiency, liver diseases
- • Patients who received systemic antipsoriatic treatment or UV treatment less than 4 weeks prior to study
- • Patients who used topical antipsoriatics within two weeks prior to study
- • Immunosuppressed Patients
About Technische Universität Dresden
Technische Universität Dresden (TU Dresden) is a leading research institution in Germany, renowned for its commitment to advancing scientific knowledge and innovation across various disciplines, including medicine and healthcare. As a clinical trial sponsor, TU Dresden leverages its cutting-edge research facilities and interdisciplinary expertise to facilitate the development of novel therapeutic interventions and improve patient outcomes. The university fosters collaboration among academic, clinical, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in the conduct of clinical research. Through its dedication to excellence and research-driven initiatives, TU Dresden plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dresden, Sachsen, Germany
Patients applied
Trial Officials
Gottfried Wozel, Professor
Principal Investigator
Technische Universität Dresden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials